FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine, namely to endocrinology, and can be used for the correction of body weight. Methods of the invention include the introduction of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and measurement of susceptibility to such treatment, where the choice of the individual for treatment (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine is administered if this individual has achieved at least 5 % weight loss after the end of the 12th week.
EFFECT: use of the invention allows to treat obesity, reduce body weight and reduce food intake, reduce the number of undesirable side effects.
32 cl, 4 ex, 2 dwg, 10 tbl
